InBioGen Co Ltd (101140)

Seoul

Currency in KRW

5,230

+200(+3.98%)

Closed·02:29:59

Fair Value

Unlock Value

Day's Range

4,815

5,240

52 wk Range

4,805

14,300

101140 Income Statement

Assess the InBioGen Co Ltd income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 101140 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

10,480.82

10,419.52

6,240.8

7,041.06

6,296.75

Total Revenues Growth

aa.aa

+2.58%

-0.58%

-40.1%

+12.82%

-10.57%

Cost Of Revenues

aa.aa

8,652.08

8,447.25

4,933.22

6,412.55

6,681.13

Gross Profit

aa.aa

1,828.74

1,972.28

1,307.58

628.51

-384.38

Gross Profit Growth

aa.aa

+137.04%

+7.85%

-33.7%

-51.93%

-161.16%

Gross Profit Margin %

aa.aa

17.45%

18.93%

20.95%

8.93%

-6.1%

Other Operating Expenses, Total

aa.aa

9,975.21

7,941.62

7,471.36

6,715.37

3,948.47

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+65.36%	-20.39%	-5.92%	-10.12%	-41.2%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	24.6	3.67	8.19	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,700.2	6,520.72	5,739.16	5,686.27	3,681.78
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	158.74	124.04	577.86	59.69	39.61

Operating Income

aa.aa

-8,146.47

-5,969.34

-6,163.78

-6,086.86

-4,332.84

Operating Income Growth

aa.aa

-54.85%

+26.72%

-3.26%

+1.25%

+28.82%

EBIT Margin %

aa.aa

-77.73%

-57.29%

-98.77%

-86.45%

-68.81%

Net Interest Expenses

aa.aa

-1,991.13

-1,863.83

1,026.43

873.55

785.92

Net Interest Expenses Growth

aa.aa

+61.92%

+6.39%

+155.07%

-14.89%

-10.03%

Interest Expense, Total

aa.aa

-3,830.16

-3,686.46

-262.15

-51.35

-78.45

Interest And Investment Income

aa.aa

1,839.03

1,822.62

1,288.57

924.91

864.37

Other Non Operating Expenses, Total

aa.aa

5,345.68

59,652.19

-21,707.05

959.14

110.07

EBT, Excl. Unusual Items

aa.aa

-4,791.92

51,819.02

-26,844.4

-4,254.16

-3,436.85

Gain (Loss) On Sale Of Assets

aa.aa

-138.43

-64.79

-168.16

61.39

Other Unusual Items, Total

aa.aa

-6,745.5

-263.58

-992.37

-1,052.47

EBT, Incl. Unusual Items

aa.aa

111,064.19

-133,902.31

11,858.81

16,122.33

-1,418.66

EBT, Incl. Unusual Items Growth

aa.aa

+345.62%

-220.56%

+108.86%

+35.95%

-108.8%

EBT, Incl. Unusual Items Margin

aa.aa

1,059.69%

-1,285.11%

190.02%

228.98%

-22.53%

Income Tax Expense

aa.aa

16,939.24

-16,952.89

Net Income to Company

aa.aa

94,124.95

-117,218.21

11,344.11

16,122.33

-1,418.66

Minority Interest

aa.aa

Net Income

aa.aa

94,124.95

-117,218.21

11,344.11

16,122.33

-1,418.66

Net Income Growth

aa.aa

+308.81%

-224.53%

+109.68%

+42.12%

-108.8%

Net Income Margin %

aa.aa

898.07%

-1,124.99%

181.77%

228.98%

-22.53%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

94,124.95

-116,949.42

11,858.81

16,122.33

-1,418.66

Basic EPS - Continuing Operations

aa.aa

35,054.16

-32,253.4

1,393.49

1,614.69

Basic EPS - Continuing Operations Growth

aa.aa

+260.73%

-192.01%

+104.32%

+15.87%

Diluted EPS - Continuing Operations

aa.aa

31,498.9

-32,253.4

1,393.49

1,614.69

Diluted EPS - Continuing Operations Growth

aa.aa

+244.43%

-202.4%

+104.32%

+15.87%

Basic Weighted Average Shares Outstanding

aa.aa

2.69

3.63

8.51

9.98

Diluted Weighted Average Shares Outstanding

aa.aa

2.99

3.63

8.51

9.98

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-7,029.21

-4,531.27

-4,939.76

-5,029.57

-3,969.35

EBITDA Growth

aa.aa

-45.91%

+35.54%

-9.02%

-1.82%

+21.08%

EBITDA Margin %

aa.aa

-67.07%

-43.49%

-79.15%

-71.43%

-63.04%

EBIT

aa.aa

-8,146.47

-5,969.34

-6,163.78

-6,086.86

-4,332.84

* In Millions of KRW (except for per share items)

FAQ

What was InBioGen Co Ltd’s revenue at year end?

At the end of the last reported fiscal year, InBioGen Co Ltd (101140) recorded total revenue of 6,297 million KRW.

How much revenue did InBioGen Co Ltd report in the most recent quarter?

In its most recent quarterly earnings report, InBioGen Co Ltd posted revenue of 786 million KRW.

What was InBioGen Co Ltd’s net income for the year?

For the full year, InBioGen Co Ltd reported net income of -1,419 million KRW.

How much net income did InBioGen Co Ltd post in the last quarter?

In the most recent quarter, InBioGen Co Ltd (101140) posted net income of -14,678 million KRW.

What was InBioGen Co Ltd’s gross profit for the year?

Gross profit for the year was reported at -384 million KRW.

How much gross profit did InBioGen Co Ltd generate last quarter?

InBioGen Co Ltd recorded gross profit of -170 million KRW in its latest quarterly report.

What was InBioGen Co Ltd’s annual operating income?

For the full year, InBioGen Co Ltd (101140) reported operating income of -4,333 million KRW.

What was InBioGen Co Ltd’s operating income last quarter?

Quarterly operating income was -980 million KRW.

What was InBioGen Co Ltd’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -978 million KRW.

What was the quarter-over-quarter change in EBITDA for InBioGen Co Ltd?

EBITDA changed by -13% million KRW compared to the last quarter.

What is InBioGen Co Ltd’s most recent gross profit margin?

The latest reported gross profit margin for InBioGen Co Ltd (101140) is -22% million KRW.

What is InBioGen Co Ltd’s most recent net income margin?

Net income margin based on recent financials is -1,867% million KRW.

What is InBioGen Co Ltd’s most recent EBIT margin?

InBioGen Co Ltd reported an EBIT margin of -125% million KRW based on current figures.

How did InBioGen Co Ltd’s revenue change compared to the previous quarter?

Revenue changed by 19% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for InBioGen Co Ltd?

In the latest quarter, gross profit changed by -36% million KRW from the previous quarter.

S&P/TSX

35,226.14

-279.70

-0.79%

S&P/TSX 60

2,083.27

-15.80

-0.75%

US 30

53,221.10

+42.7

+0.08%

US 500

7,607.00

+6.5

+0.09%

S&P 500 VIX

15.83

-0.03

-0.19%

DAX

26,124.29

+88.46

+0.34%

Dollar Index

99.91

+0.129

+0.13%

Market Movers

Name	Last	Chg. %	Vol.
RBC	293.41	-0.33%	2.56M
TELUS	13.38	-11.27%	50.34M
Bank of Montreal	251.47	+0.46%	2.34M
Toronto Dominion Bank	168.04	+0.16%	2.85M
Enbridge	76.28	-1.80%	6.03M
Shopify Inc	164.18	-4.28%	2.49M
Bank of Nova Scotia	122.97	-0.11%	2.73M

Name	Last	Chg. %	Vol.
1933 Industries	0.01	+200.00%	25.90K
International Iconic Gold Exploration	0.0150	+200.00%	286.30K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Red Lake Gold	0.0100	+100.00%	20.00K
EnviroMetal Technologies	0.01	+100.00%	1.00K
1933 Industries	0.0100	+100.00%	25.90K
Digicann Ventures	0.010	+100.00%	2.00K

Name	Last	Chg. %	Vol.
Pioneer Media Holdings	0.01	-100.00%	0.00
Lanebury Growth Capital	0.05	-68.75%	18.17K
Champion Electric	0.005	-50.00%	100.00K
BEACN Wizardry Magic	0.03	-50.00%	5.00K
CryptoStar	0.0050	-50.00%	68.70K
Molecule Holdings	0.005	-50.00%	20.11K
Digital Asset Tech	0.01	-50.00%	86.00K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	13.38	-11.27%	50.34M
Keel Infra	5.58	-1.06%	5.45M
Hut 8	151.000	-0.45%	445.58K
Celestica Inc.	463.87	-5.97%	403.37K
Canadian Natural	66.78	+0.85%	4.30M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaaa Aaaaaaaaa	102.61	+52.36%	156.34
Aa Aaa Aa A	5.34	+48.02%	7.90
Aaaa Aaaaa	19.84	+47.04%	29.17
Aa Aaaaaaa	144.91	+46.48%	212.26
Aaaaaa Aaaaa Aa	35.54	+45.08%	51.56
Aaa Aaaaaaaa Aaaa	5.25	+42.81%	7.50
A Aaaaaaaa	19.09	+42.66%	27.23

Name	Last	Upside	Fair Value
A Aaaaaa Aaaaaaaaa	102.61	+52.36%	156.34
Aa Aaa Aa A	5.34	+48.02%	7.90
Aaaa Aaaaa	19.84	+47.04%	29.17
Aa Aaaaaaa	144.91	+46.48%	212.26
Aaaaaa Aaaaa Aa	35.54	+45.08%	51.56
Aaa Aaaaaaaa Aaaa	5.25	+42.81%	7.50
A Aaaaaaaa	19.09	+42.66%	27.23

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

InBioGen Co Ltd (101140)

101140 Income Statement

FAQ

What was InBioGen Co Ltd’s revenue at year end?

How much revenue did InBioGen Co Ltd report in the most recent quarter?

What was InBioGen Co Ltd’s net income for the year?

How much net income did InBioGen Co Ltd post in the last quarter?

What was InBioGen Co Ltd’s gross profit for the year?

How much gross profit did InBioGen Co Ltd generate last quarter?

What was InBioGen Co Ltd’s annual operating income?

What was InBioGen Co Ltd’s operating income last quarter?

What was InBioGen Co Ltd’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for InBioGen Co Ltd?

What is InBioGen Co Ltd’s most recent gross profit margin?

What is InBioGen Co Ltd’s most recent net income margin?

What is InBioGen Co Ltd’s most recent EBIT margin?

How did InBioGen Co Ltd’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for InBioGen Co Ltd?

Trending Stocks